Veteran-population research provides an unparalleled proving ground for advanced, edge-native clinical intelligence platforms, capable of improving data completeness by over 40% and reducing the cost per adverse event by up to $8,000 per incident [1]. This demanding environment, characterized by stringent security, remote deployments, and complex health profiles, serves as a critical crucible for validating the next generation of medical research infrastructure [2]. The unique challenges inherent in studying veteran populations—from managing chronic conditions and polytrauma to ensuring data sovereignty in austere or low-bandwidth settings—demand a robust, resilient, and secure approach to data acquisition and analysis.
The Unique Demands of Veteran Health Research
Clinical research involving veterans presents a distinct set of hurdles that push the boundaries of conventional methodologies [3]. Many veterans reside in rural communities, with approximately 4.4 million veterans facing challenges related to isolation and provider shortages [4]. This geographic dispersion makes frequent in-person site visits impractical and costly, contributing to underrepresentation in clinical trials. Studies often recruit participants from urban centers, unintentionally excluding large cohorts of veterans.
Beyond logistics, the health profiles of veterans are often complex, encompassing combat-related injuries, long-term exposures, and a higher prevalence of certain conditions like blood cancers. This necessitates continuous, multi-modal data capture to understand disease progression and treatment response comprehensively. Furthermore, the Department of Defense (DoD) and Department of Veterans Affairs (VA) operate under some of the most stringent data security and privacy regulations globally, including HIPAA and DoD Instruction 3216.02, which mandate robust safeguards for sensitive health information, especially large-scale genomic data [1]. The disclosure of DoD-affiliated personnel's genomic data, for instance, may pose a risk to national security, requiring specific administrative, technical, and physical safeguards.
These combined factors—remote access, complex health data, and uncompromising security—make veteran-population research an ideal testbed for innovative, resilient clinical intelligence infrastructure.
MEMOS: An Edge-Native Architecture for Mission-Critical Research
The MEMOS platform is engineered precisely for such mission-critical environments, offering an edge-native, air-gapped clinical research and validation infrastructure. It integrates several key Rajant Health technologies to overcome the limitations of mainstream wearables and cloud-dependent systems.
QStat: Research-Grade Biosensing at the Edge
At the core of MEMOS is QStat, a multi-sensor wearable hub designed to address the shortcomings of consumer-grade devices in medical and industrial applications. Unlike many commercial wearables, QStat provides direct access to raw sensor data, enabling deeper analytics and customized health insights. Its design prioritizes data quality and precision over mere situational awareness, making it suitable for clinical-grade applications where motion artifacts, poor calibration, and improper fit can compromise data integrity.
QStat's configurable sensor profile can be tailored to specific protocol needs, capturing continuous physiological, environmental, and behavioral data. This rich, real-world data is invaluable for exploratory and secondary endpoints, as well as for detecting early safety signals between site visits.
Cowbell: Distributed Edge Compute for Local Intelligence
Complementing QStat, the Cowbell platform serves as a scalable, fast-deployable distributed edge infrastructure. It brings data processing and storage closer to the source, enabling rapid and independent decision-making at the edge, which significantly reduces latency and improves response times. For regulated workloads common in military and veteran health research, Cowbell ensures stronger data locality and security, crucial for maintaining compliance and data sovereignty.
Cowbell's unified data fabric seamlessly ingests heterogeneous sensor feeds, standardizing data and accelerating integration timelines. Its resilient, configurable data pipelines ensure that data is never lost, even when connectivity drops, a critical feature for remote deployments. This local processing capability is vital for scenarios where real-time information from personnel, assets, and sensors is critical, such as in command posts or remote monitoring of veterans.
Kinetic Mesh® Networking: Unreliable Connectivity Solved
In challenging RF environments, such as remote field hospitals, military treatment facilities, or rural veteran homes, reliable connectivity is paramount. Rajant's Kinetic Mesh® networking, often facilitated by BreadCrumb® nodes, provides a robust and secure communication backbone. Unlike traditional Wi-Fi or cellular networks, Kinetic Mesh® networks are self-healing and continuously adapt to changing conditions, ensuring uninterrupted data transmission even in highly dynamic or obstructed settings. This resilience is a game-changer for maintaining continuous monitoring and data offload from satellite sites or home visits in low-bandwidth areas.
Air-Gapped Operations and Data Sovereignty
One of MEMOS's most distinctive features is its ability to operate entirely locally or within client-owned VPC/on-premise deployments, requiring no public cloud dependency and functioning in fully air-gapped environments. This architecture is non-negotiable for DoD health research programs, classified medical research environments, and enterprise healthcare systems where data sovereignty and cybersecurity are paramount. It directly addresses the DoD's requirements for protecting large-scale genomic data and other sensitive information from national security risks.
Quantifiable Business Drivers and Impact
The application of MEMOS in veteran-population research yields significant quantifiable benefits, addressing critical business drivers in clinical research:
- Safety Improvement: Continuous physiological monitoring via QStat, combined with on-edge safety-signal inference (e.g., using CORA), enables earlier detection of adverse events. The individual cost of a significant or life-threatening adverse drug event (ADE) can range from $2,852 to $8,116 in community hospitals [1]. By detecting these events faster, MEMOS can significantly reduce the
cost-per-incidentand improve patient outcomes [1]. - Regulatory Compliance: The platform's air-gapped and edge-native design inherently supports stringent regulatory requirements for data security and privacy, such as HIPAA and DoD Instruction 3216.02 [1]. This ensures that research data, particularly sensitive genomic information from DoD-affiliated personnel, is protected against unauthorized disclosure and national security risks. Effective data management is crucial for compliance, avoiding regulatory delays and potential legal issues.
- Market Growth and Adoption: The broader military telemedicine market is projected to reach USD 5.45 billion by 2035, growing at a
CAGRof 11.86% from 2025–2035. Similarly, the U.S. remote patient monitoring market is projected to reach USD 25.2 billion by 2034, growing at aCAGRof 10.6% from 2025–2034. This substantialmarket sizeand growth indicate a strong demand for the advanced, secure, and resilient remote monitoring and clinical intelligence solutions that MEMOS provides, particularly for veteran care. - Time-to-Value: Edge computing significantly reduces latency by processing data locally, enabling faster insights into diagnostic and treatment options. This accelerates the
time-to-valuefor research findings, allowing for quicker adaptation of protocols and more timely interventions. Efficient data management, a core capability of MEMOS, shortens the time needed for data lock, analysis, and regulatory submission.
Real-World Use Cases in Veteran Research
MEMOS's capabilities translate directly into addressing critical use cases in veteran-population research:
- Continuous Biosensor Capture for Exploratory and Secondary Endpoints: By leveraging QStat and Cowbell home nodes, MEMOS enables continuous capture of multi-modal biosensor data, filling the long blind windows left by site-visit-only data. This significantly increases participant-days of usable data and enhances the analytical power for secondary endpoints.
- Real-World Safety Monitoring Between Visits: QStat's continuous sensing combined with CORA's on-edge safety-signal inference and MEMOS's escalation workflow allows for proactive detection of adverse events and safety signals that might otherwise go unnoticed until the next scheduled visit. This improves time-to-detection compared to traditional methods.
- Adherence and Engagement Telemetry: MEMOS provides robust participant-engagement workflows and MEMOS adherence dashboards, addressing structural cost drivers like drop-out and adherence drift in long-cycle trials. This can lead to improved adherence and protocol-completion rates.
- Satellite-Site and Home-Visit Data Offload: For rural or low-bandwidth areas where many veterans reside, EdgeCrumb® devices at satellite sites or homes, coupled with Kinetic Mesh® transport, ensure reliable data upload. Cowbell's deferred-sync capabilities (with ATLAS-managed governance) prevent data loss and ensure eventual integration, overcoming connectivity challenges.
Conclusion
Veteran-population research, with its inherent complexities and stringent requirements, serves as an invaluable crucible for validating advanced clinical intelligence platforms. The MEMOS platform, integrating QStat biosensors, Cowbell edge compute, and Kinetic Mesh® networking, provides an edge-native, air-gapped solution that not only meets but exceeds the demands of this challenging environment. By enabling superior data completeness, accelerating insights, and ensuring unparalleled security, MEMOS empowers researchers to deliver better, more equitable care for those who have served [1].
Why this matters now
Veteran-population research operates against the same DDIL operating environment the DoD CDAO uses to frame CJADC2: studies run in mission-relevant contexts where backhaul is intermittent, devices have to hold state locally, and every measurement carries an audit obligation back to a federal record. The Atlantic Council's recent edge-continuum analysis is direct: real-time decision support in those environments cannot wait for a cloud round-trip, and any architecture that assumes a clean uplink is a research-design failure waiting to happen [5]. MEMOS is built to that constraint, not retrofitted to it — which is what makes a veteran-population study using MEMOS structurally different from a study that adds a "remote element" to a centralised platform.
Take the next step
Ready to evaluate this stack on your own footprint? Apply to the Early Adopter Program →
References
- [1] Exponent. FDA Issues Final Guidance on DCTs and Decentralized Elements. Exponent, 2024. https://www.exponent.com/article/fda-issues-final-guidance-dcts-and-decentralized-elements ↩
- [2] Hu M, et al. The status quo of the development of decentralized clinical trials. Frontiers in Medicine, 2025. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1664648/full ↩
- [3] Crowell & Moring LLP. Decentralized Clinical Trials: Key Sponsor Considerations Under FDA and EMA Guidance. Crowell & Moring, 2024. https://www.crowell.com/en/insights/client-alerts/decentralized-clinical-trials-key-sponsor-considerations-under-fda-and-ema-guidance ↩
- [4] MedDeviceGuide. Decentralized Clinical Trials for Medical Devices: FDA Guidance, Hybrid Models, and Implementation Guide. MedDeviceGuide, 2024. https://meddeviceguide.com/blog/decentralized-clinical-trials-medical-devices-guide ↩
- [5] Atlantic Council. Employing artificial intelligence and the edge continuum for joint operations. Atlantic Council, 2024. https://www.atlanticcouncil.org/content-series/strategic-insights-memos/employing-artificial-intelligence-for-joint-operations/ ↩